- $20.42bn
- $21.13bn
- $4.37bn
- 89
- 37
- 92
- 85
Annual balance sheet for Illumina, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | 2025 December 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,339 | 1,054 | 2,037 | 1,220 | 1,633 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 648 | 752 | 688 | 751 | 854 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2,713 | 2,609 | 3,561 | 2,746 | 3,289 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,696 | 1,551 | 1,744 | 1,234 | 1,129 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 15,217 | 10,111 | 12,252 | 6,303 | 6,644 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,093 | 1,570 | 2,773 | 1,547 | 1,585 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4,477 | 4,366 | 5,653 | 3,930 | 3,921 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 10,740 | 5,745 | 6,599 | 2,373 | 2,723 |
| Total Liabilities & Shareholders' Equity | 15,217 | 10,111 | 12,252 | 6,303 | 6,644 |
| Total Common Shares Outstanding |